Adrian Liew

13PUBLICATIONS
62CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 23, 2026
Efficacy and safety of sibeprenlimab in IgA nephropathy: interim analysis of the China cohort in the phase 3 VISIONARY trial.

|Jul 14, 2026
Risk factor obesity: treatment standard.

|Jun 11, 2026
Humoral Response to COVID-19 Vaccines and Infection during Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION Trial.

|Dec 06, 2024
Endothelin receptor antagonists in chronic kidney disease.

J David Smeijer, Donald E Kohan, Neeraj Dhaun

|Nov 11, 2024
Establishing a peritoneal dialysis technique survival core outcome measure: A standardised outcomes in nephrology-peritoneal dialysis consensus workshop report.

Emma H Elphick, Karine E Manera, Andrea K Viecelli

|Jan 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.

Jonathan Barratt, Adrian Liew, See Cheng Yeo

Pageof 3

Frequent Collaborators

4 joint publications

Muh Geot Wong

3 joint publications

Hiddo J L Heerspink

3 joint publications

Paweena Susantitaphong

3 joint publications

Manisha Sahay